Terms: = Leukemia AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Treatment
54 results:
1. Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia.
Myers RM; Devine K; Li Y; Lawrence S; Leahy AB; Liu H; Vernau L; Callahan C; Baniewicz D; Kadauke S; McGuire R; Wertheim GB; Kulikovskaya I; Gonzalez VE; Fraietta JA; DiNofia AM; Hunger SP; Rheingold SR; Aplenc R; June CH; Grupp SA; Wray L; Maude SL
Blood Adv; 2024 May; 8(9):2182-2192. PubMed ID: 38386999
[TBL] [Abstract] [Full Text] [Related]
2. The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Visentin A; Chatzikonstantinou T; Scarfò L; Kapetanakis A; Demosthenous C; Karakatsoulis G; Minga E; Chamou D; Allsup D; Cabrero AA; Andres M; Antic D; Baile M; Baliakas P; Besikli-Dimou S; Bron D; Chatzileontiadou S; Cordoba R; Correa JG; Cuéllar-García C; De Paoli L; De Paolis MR; Delgado J; Dimou M; Donaldson D; Catherwood M; Doubek M; Efstathopoulou M; Eichhorst B; Elashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Foglietta M; Frederiksen H; Fürstenau M; García-Marco JA; García-Serra R; Collado R; Gentile M; Gimeno E; Glenthøj A; da Silva MG; Hakobyan YK; Herishanu Y; Hernández-Rivas JÁ; Herold T; Innocenti I; Itchaki G; Jaksic O; Janssens A; Kalashnikova ОB; Kalicińska E; Kater AP; Kersting S; Labrador J; Lad D; Laurenti L; Levin MD; Lista E; Lopez-Garcia A; Malerba L; Marasca R; Marchetti M; Marquet J; Mattsson M; Mauro FR; Morawska M; Motta M; Munir T; Murru R; Niemann CU; Rodrigues RN; Olivieri J; Orsucci L; Papaioannou M; Pavlovsky MA; Piskunova I; Popov VM; Quaglia FM; Quaresmini G; Qvist K; Rigolin GM; Ruchlemer R; Šimkovič M; Špaček M; Sportoletti P; Stanca O; Tadmor T; Capasso A; Del Poeta G; Gutwein O; Karlsson LK; Milosevic I; Mirás F; Reda G; Saghumyan G; Shrestha A; Te Raa D; Tonino SH; Van Der Spek E; van Gelder M; van Kampen R; Wasik-Szczepanek E; Wróbel T; Segundo LYS; Yassin M; Pocali B; Vandenberghe E; Iyengar S; Varettoni M; Vitale C; Coscia M; Rambaldi A; Montserrat E; Cuneo A; Stavroyianni N; Trentin L; Stamatopoulos K; Ghia P
Am J Hematol; 2023 Dec; 98(12):1856-1868. PubMed ID: 37772428
[TBL] [Abstract] [Full Text] [Related]
3. cyld stimulates macrophage phagocytosis of leukemic cells through STAT1 signalling in acute myeloid leukemia.
Huyen NT; Ngoc NT; Giang NH; Trang DT; Hanh HH; Binh VD; Giang NV; Canh NX; Xuan NT
PLoS One; 2023; 18(8):e0283586. PubMed ID: 37549179
[TBL] [Abstract] [Full Text] [Related]
4. Total Marrow Irradiation for Second Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Advanced Acute leukemia.
Dominietto A; Vagge S; di Grazia C; Bregante S; Raiola AM; Varaldo R; Gualandi F; Gusinu M; Barra S; Agostinelli S; Angelucci E; Hui S
Transplant Cell Ther; 2023 Aug; 29(8):506.e1-506.e6. PubMed ID: 37094701
[TBL] [Abstract] [Full Text] [Related]
5. Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy.
Salmon M; White HE; Zizkova H; Gottschalk A; Motlova E; Cerveira N; Colomer D; Coriu D; Franke GN; Gottardi E; Izzo B; Jurcek T; Lion T; Schäfer V; Venturi C; Vigneri P; Zawada M; Zuna J; Hovorkova L; Koblihova J; Klamova H; Markova MS; Srbova D; Benesova A; Polivkova V; Zackova D; Mayer J; Roeder I; Glauche I; Ernst T; Hochhaus A; Polakova KM; Cross NCP
Leukemia; 2022 Jul; 36(7):1879-1886. PubMed ID: 35676453
[TBL] [Abstract] [Full Text] [Related]
6. Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal Adenocarcinoma.
Carr RA; Hsu M; Harrington CA; Tan KS; Bains MS; Bott MJ; Ilson DH; Isbell JM; Janjigian YY; Maron SB; Park BJ; Rusch VW; Sihag S; Wu AJ; Jones DR; Ku GY; Molena D
Ann Surg; 2023 Mar; 277(3):e538-e544. PubMed ID: 34387205
[TBL] [Abstract] [Full Text] [Related]
7. Irreversible JNK blockade overcomes PD-L1-mediated resistance to chemotherapy in colorectal cancer.
Sun L; Patai ÁV; Hogenson TL; Fernandez-Zapico ME; Qin B; Sinicrope FA
Oncogene; 2021 Aug; 40(32):5105-5115. PubMed ID: 34193942
[TBL] [Abstract] [Full Text] [Related]
8. Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study).
Candoni A; Farina F; Perruccio K; Di Blasi R; Criscuolo M; Cattaneo C; Delia M; Zannier ME; Dragonetti G; Fanci R; Martino B; Del Principe MI; Fianchi L; Vianelli N; Chierichini A; Garzia M; Petruzzellis G; Nadali G; Verga L; Busca A; Pagano L
Mycoses; 2020 Oct; 63(10):1094-1100. PubMed ID: 32697010
[TBL] [Abstract] [Full Text] [Related]
9. Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study.
Ruchlemer R; Ben-Ami R; Bar-Meir M; Brown JR; Malphettes M; Mous R; Tonino SH; Soussain C; Barzic N; Messina JA; Jain P; Cohen R; Hill B; Mulligan SP; Nijland M; Herishanu Y; Benjamini O; Tadmor T; Okamoto K; Arthurs B; Gottesman B; Kater AP; Talha M; Eichhorst B; Korem M; Bogot N; De Boer F; Rowe JM; Lachish T
Mycoses; 2019 Dec; 62(12):1140-1147. PubMed ID: 31520441
[TBL] [Abstract] [Full Text] [Related]
10. Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.
Kjaer L; Skov V; Andersen MT; Aggerholm A; Clair P; Gniot M; Soeby K; Udby L; Dorff MH; Hasselbalch H; Pallisgaard N
Eur J Haematol; 2019 Jul; 103(1):26-34. PubMed ID: 30985947
[TBL] [Abstract] [Full Text] [Related]
11. Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1.
Pfeifer H; Cazzaniga G; van der Velden VHJ; Cayuela JM; Schäfer B; Spinelli O; Akiki S; Avigad S; Bendit I; Borg K; Cavé H; Elia L; Reshmi SC; Gerrard G; Hayette S; Hermanson M; Juh A; Jurcek T; Chillón MC; Homburg C; Martinelli G; Kairisto V; Lange T; Lion T; Mueller MC; Pane F; Rai L; Damm-Welk C; Sacha T; Schnittger S; Touloumenidou T; Valerhaugen H; Vandenberghe P; Zuna J; Serve H; Herrmann E; Markovic S; Dongen JJMV; Ottmann OG
Leukemia; 2019 Aug; 33(8):1910-1922. PubMed ID: 30858550
[TBL] [Abstract] [Full Text] [Related]
12. A zinc Schiff base complex inhibits cancer progression both in vivo and in vitro by inducing apoptosis.
Banerjee A; Banerjee K; Sinha A; Das S; Majumder S; Majumdar S; Choudhuri SK
Environ Toxicol Pharmacol; 2017 Dec; 56():383-392. PubMed ID: 29145169
[TBL] [Abstract] [Full Text] [Related]
13. 4-aryl/heteroaryl-4H-fused Pyrans as Anti-proliferative Agents: Design, Synthesis and Biological Evaluation.
Kumar D; Singh G; Sharma P; Qayum A; Mahajan G; Mintoo MJ; Singh SK; Mondhe DM; Bedi PMS; Jain SK; Gupta GK
Anticancer Agents Med Chem; 2018; 18(1):57-73. PubMed ID: 28925877
[TBL] [Abstract] [Full Text] [Related]
14. Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma.
Tong Z; Chatterjee D; Deng D; Veeranki O; Mejia A; Ajani JA; Hofstetter W; Lin S; Guha S; Kopetz S; Krishnan S; Maru D
Oncotarget; 2017 Apr; 8(17):28696-28710. PubMed ID: 28404924
[TBL] [Abstract] [Full Text] [Related]
15. Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia.
Saleh LM; Wang W; Herman SE; Saba NS; Anastas V; Barber E; Corrigan-Cummins M; Farooqui M; Sun C; Sarasua SM; Zhao Z; Abousamra NK; Elbaz O; Abdelghaffar HA; Wiestner A; Calvo KR
Leukemia; 2017 Feb; 31(2):340-349. PubMed ID: 27431016
[TBL] [Abstract] [Full Text] [Related]
16. High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid.
Wu W; Zhu H; Fu Y; Shen W; Miao K; Hong M; Xu W; Fan L; Young KH; Liu P; Li J
Oncotarget; 2016 Apr; 7(16):21631-43. PubMed ID: 26950276
[TBL] [Abstract] [Full Text] [Related]
17. cyld Regulates Noscapine Activity in Acute Lymphoblastic leukemia via a Microtubule-Dependent Mechanism.
Yang Y; Ran J; Sun L; Sun X; Luo Y; Yan B; Tala ; Liu M; Li D; Zhang L; Bao G; Zhou J
Theranostics; 2015; 5(7):656-66. PubMed ID: 25897332
[TBL] [Abstract] [Full Text] [Related]
18. Cellular proteolytic modification of tumor-suppressor cyld is critical for the initiation of human T-cell acute lymphoblastic leukemia.
Arora M; Kaul D; Varma N; Marwaha RK
Blood Cells Mol Dis; 2015 Jan; 54(1):132-8. PubMed ID: 25130432
[TBL] [Abstract] [Full Text] [Related]
19. MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits cyld in T-cell acute lymphoblastic leukemia.
Ye H; Liu X; Lv M; Wu Y; Kuang S; Gong J; Yuan P; Zhong Z; Li Q; Jia H; Sun J; Chen Z; Guo AY
Nucleic Acids Res; 2012 Jul; 40(12):5201-14. PubMed ID: 22362744
[TBL] [Abstract] [Full Text] [Related]
20. Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of cyld gene by LEF1.
Liu P; Xu B; Shen W; Zhu H; Wu W; Fu Y; Chen H; Dong H; Zhu Y; Miao K; Xu W; Li J
Leukemia; 2012 Jun; 26(6):1293-300. PubMed ID: 22157808
[TBL] [Abstract] [Full Text] [Related]
[Next]
